Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
49
INFU Quote, Financials, Valuation and Earnings
Last price:
$7.95
Seasonality move
:
0.27%
Day range:
$7.80 - $8.08
52-week range:
$4.61 - $11.04
Dividend yield:
0%
P/E ratio:
30.40x
P/S ratio:
1.20x
P/B ratio:
2.91x
Volume:
118.8K
Avg. volume:
135.9K
1-year change:
-2.45%
Market cap:
$161.7M
Revenue:
$134.9M
EPS (TTM):
$0.26
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
INFU
InfuSystem Holdings, Inc.
|
$36.7M | $0.05 | -0.47% | 39.86% | $14.20 |
|
ABT
Abbott Laboratories
|
$11.8B | $1.49 | 6.14% | 54.88% | $133.39 |
|
ARAY
Accuray, Inc.
|
$100.9M | -$0.11 | -1.19% | -296.83% | $2.53 |
|
ATEC
Alphatec Holdings, Inc.
|
$212.3M | $0.04 | 20.01% | -91.85% | $24.62 |
|
ICUI
ICU Medical, Inc.
|
$541.2M | $1.69 | -11.78% | 316.67% | $182.67 |
|
PSTV
Plus Therapeutics, Inc.
|
$1.2M | -$0.04 | 22.78% | -97.49% | $5.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
INFU
InfuSystem Holdings, Inc.
|
$7.95 | $14.20 | $161.7M | 30.40x | $0.00 | 0% | 1.20x |
|
ABT
Abbott Laboratories
|
$112.21 | $133.39 | $195.1B | 30.19x | $0.63 | 2.14% | 4.43x |
|
ARAY
Accuray, Inc.
|
$0.54 | $2.53 | $60.7M | 149.00x | $0.00 | 0% | 0.14x |
|
ATEC
Alphatec Holdings, Inc.
|
$13.01 | $24.62 | $1.9B | -- | $0.00 | 0% | 2.65x |
|
ICUI
ICU Medical, Inc.
|
$157.03 | $182.67 | $3.9B | 6,383.33x | $0.00 | 0% | 1.74x |
|
PSTV
Plus Therapeutics, Inc.
|
$0.28 | $5.50 | $37.8M | -- | $0.00 | 0% | 4.41x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
INFU
InfuSystem Holdings, Inc.
|
30.8% | 4.209 | 11.73% | 1.35x |
|
ABT
Abbott Laboratories
|
21.33% | 0.141 | 6.97% | 1.05x |
|
ARAY
Accuray, Inc.
|
76.53% | 1.394 | 177.87% | 0.52x |
|
ATEC
Alphatec Holdings, Inc.
|
94.39% | 1.400 | 27.26% | 1.21x |
|
ICUI
ICU Medical, Inc.
|
38.83% | 0.155 | 38.28% | 1.01x |
|
PSTV
Plus Therapeutics, Inc.
|
0.41% | -1.387 | 0.02% | 1.22x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
INFU
InfuSystem Holdings, Inc.
|
$20.3M | $3.8M | 6.43% | 9.93% | 10.45% | $8.4M |
|
ABT
Abbott Laboratories
|
$6.1B | $2.4B | 10.13% | 12.91% | 20.68% | $2.6B |
|
ARAY
Accuray, Inc.
|
$24.1M | -$5.5M | -14.23% | -60.6% | -5.37% | -$21.6M |
|
ATEC
Alphatec Holdings, Inc.
|
$118.1M | -$9.4M | -25.96% | -1495.13% | -4.79% | $3.1M |
|
ICUI
ICU Medical, Inc.
|
$202.1M | $25.2M | 0.02% | 0.04% | 4.67% | $34.2M |
|
PSTV
Plus Therapeutics, Inc.
|
$1.3M | -$4.5M | -- | -- | -320.83% | -$2.6M |
InfuSystem Holdings, Inc. vs. Competitors
-
Which has Higher Returns INFU or ABT?
Abbott Laboratories has a net margin of 6.19% compared to InfuSystem Holdings, Inc.'s net margin of 15.71%. InfuSystem Holdings, Inc.'s return on equity of 9.93% beat Abbott Laboratories's return on equity of 12.91%.
Company Gross Margin Earnings Per Share Invested Capital INFUInfuSystem Holdings, Inc.55.65% $0.11 $80.2M ABTAbbott Laboratories53.5% $1.03 $66.9B -
What do Analysts Say About INFU or ABT?
InfuSystem Holdings, Inc. has a consensus price target of $14.20, signalling upside risk potential of 78.62%. On the other hand Abbott Laboratories has an analysts' consensus of $133.39 which suggests that it could grow by 18.88%. Given that InfuSystem Holdings, Inc. has higher upside potential than Abbott Laboratories, analysts believe InfuSystem Holdings, Inc. is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings INFUInfuSystem Holdings, Inc.5 0 0 ABTAbbott Laboratories16 7 0 -
Is INFU or ABT More Risky?
InfuSystem Holdings, Inc. has a beta of 1.674, which suggesting that the stock is 67.352% more volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.138%.
-
Which is a Better Dividend Stock INFU or ABT?
InfuSystem Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 2.14% to investors and pays a quarterly dividend of $0.63 per share. InfuSystem Holdings, Inc. pays -- of its earnings as a dividend. Abbott Laboratories pays out 64.54% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios INFU or ABT?
InfuSystem Holdings, Inc. quarterly revenues are $36.5M, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. InfuSystem Holdings, Inc.'s net income of $2.3M is lower than Abbott Laboratories's net income of $1.8B. Notably, InfuSystem Holdings, Inc.'s price-to-earnings ratio is 30.40x while Abbott Laboratories's PE ratio is 30.19x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InfuSystem Holdings, Inc. is 1.20x versus 4.43x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INFUInfuSystem Holdings, Inc.1.20x 30.40x $36.5M $2.3M ABTAbbott Laboratories4.43x 30.19x $11.5B $1.8B
-
Which has Higher Returns INFU or ARAY?
Accuray, Inc. has a net margin of 6.19% compared to InfuSystem Holdings, Inc.'s net margin of -13.47%. InfuSystem Holdings, Inc.'s return on equity of 9.93% beat Accuray, Inc.'s return on equity of -60.6%.
Company Gross Margin Earnings Per Share Invested Capital INFUInfuSystem Holdings, Inc.55.65% $0.11 $80.2M ARAYAccuray, Inc.23.54% -$0.11 $227.6M -
What do Analysts Say About INFU or ARAY?
InfuSystem Holdings, Inc. has a consensus price target of $14.20, signalling upside risk potential of 78.62%. On the other hand Accuray, Inc. has an analysts' consensus of $2.53 which suggests that it could grow by 371.7%. Given that Accuray, Inc. has higher upside potential than InfuSystem Holdings, Inc., analysts believe Accuray, Inc. is more attractive than InfuSystem Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings INFUInfuSystem Holdings, Inc.5 0 0 ARAYAccuray, Inc.2 0 0 -
Is INFU or ARAY More Risky?
InfuSystem Holdings, Inc. has a beta of 1.674, which suggesting that the stock is 67.352% more volatile than S&P 500. In comparison Accuray, Inc. has a beta of 1.151, suggesting its more volatile than the S&P 500 by 15.124%.
-
Which is a Better Dividend Stock INFU or ARAY?
InfuSystem Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Accuray, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InfuSystem Holdings, Inc. pays -- of its earnings as a dividend. Accuray, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INFU or ARAY?
InfuSystem Holdings, Inc. quarterly revenues are $36.5M, which are smaller than Accuray, Inc. quarterly revenues of $102.2M. InfuSystem Holdings, Inc.'s net income of $2.3M is higher than Accuray, Inc.'s net income of -$13.8M. Notably, InfuSystem Holdings, Inc.'s price-to-earnings ratio is 30.40x while Accuray, Inc.'s PE ratio is 149.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InfuSystem Holdings, Inc. is 1.20x versus 0.14x for Accuray, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INFUInfuSystem Holdings, Inc.1.20x 30.40x $36.5M $2.3M ARAYAccuray, Inc.0.14x 149.00x $102.2M -$13.8M
-
Which has Higher Returns INFU or ATEC?
Alphatec Holdings, Inc. has a net margin of 6.19% compared to InfuSystem Holdings, Inc.'s net margin of -14.54%. InfuSystem Holdings, Inc.'s return on equity of 9.93% beat Alphatec Holdings, Inc.'s return on equity of -1495.13%.
Company Gross Margin Earnings Per Share Invested Capital INFUInfuSystem Holdings, Inc.55.65% $0.11 $80.2M ATECAlphatec Holdings, Inc.60.12% -$0.19 $626.3M -
What do Analysts Say About INFU or ATEC?
InfuSystem Holdings, Inc. has a consensus price target of $14.20, signalling upside risk potential of 78.62%. On the other hand Alphatec Holdings, Inc. has an analysts' consensus of $24.62 which suggests that it could grow by 89.2%. Given that Alphatec Holdings, Inc. has higher upside potential than InfuSystem Holdings, Inc., analysts believe Alphatec Holdings, Inc. is more attractive than InfuSystem Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings INFUInfuSystem Holdings, Inc.5 0 0 ATECAlphatec Holdings, Inc.8 1 0 -
Is INFU or ATEC More Risky?
InfuSystem Holdings, Inc. has a beta of 1.674, which suggesting that the stock is 67.352% more volatile than S&P 500. In comparison Alphatec Holdings, Inc. has a beta of 1.013, suggesting its more volatile than the S&P 500 by 1.34%.
-
Which is a Better Dividend Stock INFU or ATEC?
InfuSystem Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alphatec Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InfuSystem Holdings, Inc. pays -- of its earnings as a dividend. Alphatec Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INFU or ATEC?
InfuSystem Holdings, Inc. quarterly revenues are $36.5M, which are smaller than Alphatec Holdings, Inc. quarterly revenues of $196.5M. InfuSystem Holdings, Inc.'s net income of $2.3M is higher than Alphatec Holdings, Inc.'s net income of -$28.6M. Notably, InfuSystem Holdings, Inc.'s price-to-earnings ratio is 30.40x while Alphatec Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InfuSystem Holdings, Inc. is 1.20x versus 2.65x for Alphatec Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INFUInfuSystem Holdings, Inc.1.20x 30.40x $36.5M $2.3M ATECAlphatec Holdings, Inc.2.65x -- $196.5M -$28.6M
-
Which has Higher Returns INFU or ICUI?
ICU Medical, Inc. has a net margin of 6.19% compared to InfuSystem Holdings, Inc.'s net margin of -2.91%. InfuSystem Holdings, Inc.'s return on equity of 9.93% beat ICU Medical, Inc.'s return on equity of 0.04%.
Company Gross Margin Earnings Per Share Invested Capital INFUInfuSystem Holdings, Inc.55.65% $0.11 $80.2M ICUIICU Medical, Inc.37.41% -$0.64 $3.5B -
What do Analysts Say About INFU or ICUI?
InfuSystem Holdings, Inc. has a consensus price target of $14.20, signalling upside risk potential of 78.62%. On the other hand ICU Medical, Inc. has an analysts' consensus of $182.67 which suggests that it could grow by 16.33%. Given that InfuSystem Holdings, Inc. has higher upside potential than ICU Medical, Inc., analysts believe InfuSystem Holdings, Inc. is more attractive than ICU Medical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings INFUInfuSystem Holdings, Inc.5 0 0 ICUIICU Medical, Inc.3 1 0 -
Is INFU or ICUI More Risky?
InfuSystem Holdings, Inc. has a beta of 1.674, which suggesting that the stock is 67.352% more volatile than S&P 500. In comparison ICU Medical, Inc. has a beta of 0.794, suggesting its less volatile than the S&P 500 by 20.551%.
-
Which is a Better Dividend Stock INFU or ICUI?
InfuSystem Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ICU Medical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InfuSystem Holdings, Inc. pays -- of its earnings as a dividend. ICU Medical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INFU or ICUI?
InfuSystem Holdings, Inc. quarterly revenues are $36.5M, which are smaller than ICU Medical, Inc. quarterly revenues of $540.3M. InfuSystem Holdings, Inc.'s net income of $2.3M is higher than ICU Medical, Inc.'s net income of -$15.7M. Notably, InfuSystem Holdings, Inc.'s price-to-earnings ratio is 30.40x while ICU Medical, Inc.'s PE ratio is 6,383.33x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InfuSystem Holdings, Inc. is 1.20x versus 1.74x for ICU Medical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INFUInfuSystem Holdings, Inc.1.20x 30.40x $36.5M $2.3M ICUIICU Medical, Inc.1.74x 6,383.33x $540.3M -$15.7M
-
Which has Higher Returns INFU or PSTV?
Plus Therapeutics, Inc. has a net margin of 6.19% compared to InfuSystem Holdings, Inc.'s net margin of -316.61%. InfuSystem Holdings, Inc.'s return on equity of 9.93% beat Plus Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital INFUInfuSystem Holdings, Inc.55.65% $0.11 $80.2M PSTVPlus Therapeutics, Inc.93.84% -$0.04 $5.1M -
What do Analysts Say About INFU or PSTV?
InfuSystem Holdings, Inc. has a consensus price target of $14.20, signalling upside risk potential of 78.62%. On the other hand Plus Therapeutics, Inc. has an analysts' consensus of $5.50 which suggests that it could grow by 1900%. Given that Plus Therapeutics, Inc. has higher upside potential than InfuSystem Holdings, Inc., analysts believe Plus Therapeutics, Inc. is more attractive than InfuSystem Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings INFUInfuSystem Holdings, Inc.5 0 0 PSTVPlus Therapeutics, Inc.4 0 0 -
Is INFU or PSTV More Risky?
InfuSystem Holdings, Inc. has a beta of 1.674, which suggesting that the stock is 67.352% more volatile than S&P 500. In comparison Plus Therapeutics, Inc. has a beta of 0.886, suggesting its less volatile than the S&P 500 by 11.364%.
-
Which is a Better Dividend Stock INFU or PSTV?
InfuSystem Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InfuSystem Holdings, Inc. pays -- of its earnings as a dividend. Plus Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INFU or PSTV?
InfuSystem Holdings, Inc. quarterly revenues are $36.5M, which are larger than Plus Therapeutics, Inc. quarterly revenues of $1.4M. InfuSystem Holdings, Inc.'s net income of $2.3M is higher than Plus Therapeutics, Inc.'s net income of -$4.4M. Notably, InfuSystem Holdings, Inc.'s price-to-earnings ratio is 30.40x while Plus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InfuSystem Holdings, Inc. is 1.20x versus 4.41x for Plus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INFUInfuSystem Holdings, Inc.1.20x 30.40x $36.5M $2.3M PSTVPlus Therapeutics, Inc.4.41x -- $1.4M -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
